首页|Mitigating gut immune adverse effects in CTLA-4 blockade for antitumor efficacy
Mitigating gut immune adverse effects in CTLA-4 blockade for antitumor efficacy
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
万方数据
维普
Shijun He、Jianping Zuo、Zemin Lin
展开 >
Laboratory of Immunopharmacology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China
Innovation Research Institute of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
School of Pharmacy,University of Chinese Academy of Sciences,Beijing 100049,China
National Natural Science Foundation of ChinaShanghai Municipal Science and Technology Major Project
万方数据
维普
